Our AudioPressReleases (APRs) are designed to help companies reach audio listeners in the consumer, investment and business communities, wherever they are and whenever they want.
An increasing number of consumers digest their news, education and entertainment in audio format – be it audiobooks, podcasts, radio or other medium. A leader in corporate communications, IBN also values the spoken word.
An APR is an extension of a traditional news release. Like paving a road, this audio platform is executed in strategic layers that build exponential value and maximize reach.
It starts with a well-written news release, enhanced by professional editors on our press desk. The news is disseminated through the circuit of your choice – ranging from U.S. state-level to global distribution with 12 translations – and then delivered to voice-over talent who use the content as script to produce the final audio version.
Adequate distribution of the APR is comprised of several layers that pave the way to optimal market reach. Similar to the initial news release, your APR is distributed through the target circuit. Shortly after this audio version crosses the wire, it is covered in a InvestorNewsBreak and sent to IBN’s network of more than 5,000 distribution points.
This layered process allows for a fluent, controlled connection with the listeners to build intrigue and brand familiarity. APRs are most efficient when used in tandem with IBN’s full suite of corporate communication solutions.
Newly added distribution channels now include 50+ Over The Top (OTT) Platforms such as Apple TV, ROKU, Google Play and more.
Recent AudioPressReleases
- DeFi Technologies Inc. Featured in Syndicated Broadcast Covering Investment into SEBA Bank, a Swiss Global Digital Assets Pioneer
- FuelPositive Corp. Featured in Syndicated Broadcast Covering Filing of Annual Audited Financial Statements and Release of Corporate Update
- CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme